IgA Vasculitis Developed as an Adverse Effect of Tofacitinib Taken for Rheumatoid Arthritis

Tofacitinib is a new small-molecule inhibitor of the JAK/STAT signaling pathway used to treat rheumatoid arthritis. We herein report a case of IgA vasculitis apparently caused by tofacitinib. A 67-year-old woman with rheumatoid arthritis developed IgA vasculitis after taking tofacitinib for 6 months...

Descripción completa

Detalles Bibliográficos
Autores principales: Itoh, Izumi, Kasuno, Kenji, Yamamoto, Chie, Takahashi, Naoki, Shimizu, Hisanori, Ojima, Tomohiro, Hayashi, Seigaku, Kimura, Hideki, Iwano, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118374/
https://www.ncbi.nlm.nih.gov/pubmed/31813912
http://dx.doi.org/10.2169/internalmedicine.3668-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118374/
https://www.ncbi.nlm.nih.gov/pubmed/31813912
http://dx.doi.org/10.2169/internalmedicine.3668-19

Ejemplares similares